Comparing Vero and MDCK cells for influenza A virus production in microcarrier systems

作者: Y. Genzel , C. Dietzsch , U. Reichl

DOI: 10.1007/978-90-481-3419-9_109

关键词:

摘要: Each year discussions on sufficient preparedness against an influenza pandemic are coming up. Currently, several new approaches for the manufacturing of effective vaccines under investigation. These include, baculovirus systems recombinant vaccines, use virus like particles or introduction designer cells as host cells. Furthermore, processes using established continuous cell lines being licensed. The favorite at moment are: Vero and MDCK

参考文章(7)
[edited by] Raymond E. Spier., Encyclopedia of cell technology Wiley-Interscience. ,(2000)
M.G. Pau, C. Ophorst, M.H. Koldijk, G. Schouten, M. Mehtali, F. Uytdehaag, The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines Vaccine. ,vol. 19, pp. 2716- 2721 ,(2001) , 10.1016/S0264-410X(00)00508-9
R Youil, Q Su, T.J Toner, C Szymkowiak, W-S Kwan, B Rubin, L Petrukhin, I Kiseleva, A.R Shaw, D DiStefano, Comparative study of influenza virus replication in Vero and MDCK cell lines Journal of Virological Methods. ,vol. 120, pp. 23- 31 ,(2004) , 10.1016/J.JVIROMET.2004.03.011
Y Genzel, I Behrendt, S König, H Sann, U Reichl, Metabolism of MDCK Cells during cell growth and influenza virus production in large-scale microcarrier culture Vaccine. ,vol. 22, pp. 2202- 2208 ,(2004) , 10.1016/J.VACCINE.2003.11.041
John G. Aunins, Viral Vaccine Production in Cell Culture Encyclopedia of Cell Technology. pp. 1- 35 ,(2003) , 10.1002/0471250570.SPI105